Recent Evolution in the Management of Lymph Node Metastases in Melanoma
Authors:
Open Access
- 19 March 2021
- journal article
- research article
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 14, 64-71
Abstract
Introduction. Based upon two large randomized international clinical trials (German Dermatologic Cooperative Oncology Group (DeCOG-SLT) and Multicenter Selective Lymphadenectomy Trial II (MSLT-II)) which were published in 2016 and 2017, respectively, active surveillance has been demonstrated to have equivalent survival outcomes to completion lymphadenectomy (CLND) for a subset of patients who have microscopic lymph node disease. In this study, we examined the changes in national practice patterns regarding the utilization of CLND after positive sentinel lymph node biopsy (SLNB). Methods. Using the National Cancer Database, we examined CLND utilization in SLN-positive patients diagnosed with melanoma between 2012 and 2016. A hierarchal logistical regression model with hospital-level random intercepts was constructed to examine the factors associated with SLNB followed by observation vs. SLNB with CLND. Results. Of the 148,982 patients identified, 43% (n = 63,358) underwent SLNB, and 10.3% (n = 6,551) had a SLNB with microscopic disease. CLND was performed for 57% (n = 2,817) of these patients. Patients were more likely to undergo CLND if they were < 55 years of age (OR, 0.687; p =Keywords
This publication has 31 references indexed in Scilit:
- Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion LymphadenectomyAnnals of Surgical Oncology, 2009
- Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous MelanomaAnnals of Surgical Oncology, 2009
- Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2009
- Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With MelanomaJournal of Clinical Oncology, 2008
- Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United StatesAnnals of Surgical Oncology, 2008
- Morbidity and Recurrence After Completion Lymph Node Dissection Following Sentinel Lymph Node Biopsy in Cutaneous Malignant MelanomaAnnals of Surgery, 2008
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Sentinel and Nonsentinel Node Status in Stage IB and II Melanoma Patients: Two-Step Prognostic Indicators of SurvivalJournal of Clinical Oncology, 2006
- The Microanatomic Location of Metastatic Melanoma in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node InvolvementJournal of Clinical Oncology, 2004
- The National Cancer Data Base: A clinical surveillance and quality improvement toolJournal of Surgical Oncology, 2003